LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 12 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 2. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 12 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 2. - Dataset (ID:20249)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 107 of 166
Next
>>
>
2651 to 2675 of 4140 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Timepoint	Timepoint Unit	Mean Total Cell Count Before Treatment	Mean Total Cell Count After Treatment	Mean Total Control Cell Count	Mean Relative Cell Count	Mean Normalized Growth Rate Inhibition Value
BT-20	Pelitinib	3.33	uM	LJP5	72	hr	1334	2711	4033	0.6718	0.5580
BT-20	Pelitinib	10	uM	LJP5	72	hr	1334	591	4033	0.1467	-0.4000
BT-20	Luminespib	0.04	uM	LJP5	72	hr	1334	980	4033	0.2432	-0.1759
BT-20	Luminespib	0.12	uM	LJP5	72	hr	1334	945	4033	0.2344	-0.1947
BT-20	Luminespib	0.37	uM	LJP5	72	hr	1334	949	4033	0.2352	-0.1930
BT-20	Luminespib	1.11	uM	LJP5	72	hr	1334	974	4033	0.2418	-0.1789
BT-20	Luminespib	3.33	uM	LJP5	72	hr	1334	970	4033	0.2405	-0.1818
BT-20	Luminespib	10	uM	LJP5	72	hr	1334	1000	4033	0.2482	-0.1653
BT-20	AZD8330	0.04	uM	LJP5	72	hr	1334	3067	4033	0.7604	0.6841
BT-20	AZD8330	0.12	uM	LJP5	72	hr	1334	3347	4033	0.8300	0.7794
BT-20	AZD8330	0.37	uM	LJP5	72	hr	1334	3272	4033	0.8121	0.7556
BT-20	AZD8330	1.11	uM	LJP5	72	hr	1334	3298	4033	0.8184	0.7641
BT-20	AZD8330	3.33	uM	LJP5	72	hr	1334	3341	4033	0.8293	0.7789
BT-20	AZD8330	10	uM	LJP5	72	hr	1334	3412	4033	0.8457	0.8000
BT-20	TGX221	0.04	uM	LJP5	72	hr	1334	3594	4033	0.8906	0.8587
BT-20	TGX221	0.12	uM	LJP5	72	hr	1334	3991	4033	0.9891	0.9855
BT-20	TGX221	0.37	uM	LJP5	72	hr	1334	4135	4033	1.0253	1.0310
BT-20	TGX221	1.11	uM	LJP5	72	hr	1334	4075	4033	1.0095	1.0096
BT-20	TGX221	3.33	uM	LJP5	72	hr	1334	4317	4033	1.0704	1.0868
BT-20	TGX221	10	uM	LJP5	72	hr	1334	4133	4033	1.0249	1.0312
BT-20	GSK1059615	0.04	uM	LJP5	72	hr	1334	4146	4033	1.0285	1.0361
BT-20	GSK1059615	0.04	uM	LJP6	72	hr	1334	3858	3925	0.9834	0.9774
BT-20	GSK1059615	0.12	uM	LJP5	72	hr	1334	3234	4033	0.8019	0.7414
BT-20	GSK1059615	0.12	uM	LJP6	72	hr	1334	3206	3925	0.8175	0.7526
BT-20	GSK1059615	0.37	uM	LJP5	72	hr	1334	1606	4033	0.3983	0.1229

|<
<<
Previous
Page 107 of 166
Next
>>
>
2651 to 2675 of 4140 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 12 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 2. - Dataset (ID:20249)